CRP and inflammatory bowel disease: ROC curve analysis was performed to assess the ability of oxidative stress–related biomarkers to distinguish between active IBD and remission based on clinical, CRP, calprotectin, and endoscopic criteria at the final follow-up (Visit 3), reflecting outcomes after approximately 6 months of therapy with biologics.